{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:49:32Z","timestamp":1773190172185,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1124\/jpet.118.254466","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T21:45:51Z","timestamp":1544823951000},"page":"742-750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance"],"prefix":"10.1016","volume":"370","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8856-0317","authenticated-orcid":false,"given":"Hayley B.","family":"Schultz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-0391","authenticated-orcid":false,"given":"Miia","family":"Kovalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl F.","family":"Peressin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8920-1391","authenticated-orcid":false,"given":"Nicky","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5401-7535","authenticated-orcid":false,"given":"Clive A.","family":"Prestidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.254466_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0731-7085(98)00235-0","article-title":"PH-metric log P 11. pKa determination of water-insoluble drugs in organic solvent-water mixtures","volume":"20","author":"Avdeef","year":"1999","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/jpet.118.254466_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1011954332221","article-title":"pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs","volume":"15","author":"Avdeef","year":"1998","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.118.254466_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejpb.2009.03.001","article-title":"Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS)","volume":"72","author":"Balakrishnan","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.118.254466_bib4","first-page":"1","article-title":"Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges","author":"Bremmell","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1124\/jpet.118.254466_bib5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/jps.23406","article-title":"Tableting lipid-based formulations for oral drug delivery: a case study with silica nanoparticle-lipid-mannitol hybrid microparticles","volume":"102","author":"Bremmell","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.118.254466_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2009.06.001","article-title":"Lipid--an emerging platform for oral delivery of drugs with poor bioavailability","volume":"73","author":"Chakraborty","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.118.254466_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejps.2004.08.003","article-title":"Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols","volume":"23","author":"Christensen","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.118.254466_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-015-9824-7","article-title":"Novel nanostructured solid materials for modulating oral drug delivery from solid-state lipid-based drug delivery systems","volume":"18","author":"Dening","year":"2016","journal-title":"AAPS J"},{"key":"10.1124\/jpet.118.254466_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpb.2016.01.010","article-title":"Silica encapsulated lipid-based drug delivery systems for reducing the fed\/fasted variations of ziprasidone in vitro","volume":"101","author":"Dening","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.118.254466_bib10","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1021\/acs.molpharmaceut.8b00555","article-title":"Montmorillonite and laponite clay materials for the solidification of lipid-based formulations for the basic drug blonanserin: in vitro and in vivo investigations","volume":"15","author":"Dening","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.118.254466_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/17425255.4.1.65","article-title":"In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability","volume":"4","author":"Fatouros","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.118.254466_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50years of oral lipid-based formulations: provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.118.254466_bib13","series-title":"Computional Toxicology","first-page":"377","article-title":"Non-compartmental analysis","author":"Gabrielsson","year":"2012"},{"key":"10.1124\/jpet.118.254466_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.addr.2007.05.006","article-title":"Oral lipid-based formulations","volume":"59","author":"Hauss","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.118.254466_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","article-title":"The impact of medication regimen factors on adherence to chronic treatment: a review of literature","volume":"31","author":"Ingersoll","year":"2008","journal-title":"J Behav Med"},{"key":"10.1124\/jpet.118.254466_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.addr.2007.09.006","article-title":"Approaches for the development of solid and semi-solid lipid-based formulations","volume":"60","author":"Jannin","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.118.254466_bib17","article-title":"Solidification to improve the biopharmaceutical performance of SEDDS: opportunities and challenges","author":"Joyce","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.118.254466_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.08.001","article-title":"Engineering intelligent particle-lipid composites that control lipase-mediated digestion","volume":"260","author":"Joyce","year":"2018","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1124\/jpet.118.254466_bib19","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1021\/acs.molpharmaceut.7b00676","article-title":"Comparison across three hybrid lipid-based drug delivery systems for improving the oral absorption of the poorly water-soluble weak base cinnarizine","volume":"14","author":"Joyce","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.118.254466_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11095-015-1829-5","article-title":"The precipitation behavior of poorly water-soluble drugs with an emphasis on the digestion of lipid based formulations","volume":"33","author":"Khan","year":"2016","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.118.254466_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02652048.2011.651497","article-title":"Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier","volume":"29","author":"Kim","year":"2012","journal-title":"J Microencapsul"},{"key":"10.1124\/jpet.118.254466_bib22","series-title":"Formulating Poorly Water Soluble Drugs","first-page":"295","article-title":"Lipid-based formulations","author":"LaFountaine","year":"2016"},{"key":"10.1124\/jpet.118.254466_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijpharm.2017.05.036","article-title":"Overview of solidification techniques for self-emulsifying drug delivery systems from industrial perspective","volume":"533","author":"Mandi\u0107","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.118.254466_bib24","series-title":"UK public assessment report: Nurofen 400mg tablets (ibuprofen)","first-page":"1","year":"2017"},{"key":"10.1124\/jpet.118.254466_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejpb.2018.05.028","article-title":"Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro","volume":"129","author":"Meola","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.118.254466_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2013.01.012","article-title":"Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: an in vivo evaluation","volume":"167","author":"Nguyen","year":"2013","journal-title":"J Control Release"},{"issue":"Suppl 1","key":"10.1124\/jpet.118.254466_bib27","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S0169-409X(01)00182-X","article-title":"In vitro assessment of oral lipid based formulations","volume":"50","author":"Porter","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.118.254466_bib28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1023\/B:PHAM.0000036914.22132.cc","article-title":"Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation","volume":"21","author":"Porter","year":"2004","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.118.254466_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.118.254466_bib30","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jps.20444","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen","volume":"94","author":"Potthast","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.118.254466_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.118.254466_bib32","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1021\/acs.molpharmaceut.5b00622","article-title":"Pluronic-functionalized silica\u2013lipid hybrid microparticles: improving the oral delivery of poorly water-soluble weak bases","volume":"12","author":"Rao","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.118.254466_bib33","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2217\/nnm.14.37","article-title":"Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin","volume":"9","author":"Rao","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"10.1124\/jpet.118.254466_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2017.12.012","article-title":"Supersaturated silica-lipid hybrids (super-SLH): an improved solid-state lipid-based oral drug delivery system with enhanced drug loading","volume":"125","author":"Schultz","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.118.254466_bib35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/mp900063t","article-title":"Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs","volume":"6","author":"Simovic","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.118.254466_bib36","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s11095-011-0458-x","article-title":"Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib","volume":"28","author":"Tan","year":"2011","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.118.254466_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s13346-013-0172-9","article-title":"First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen","volume":"4","author":"Tan","year":"2014","journal-title":"Drug Deliv Transl Res"},{"key":"10.1124\/jpet.118.254466_bib38","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1007\/s11095-013-1107-3","article-title":"Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance","volume":"30","author":"Tan","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.118.254466_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2008.10.014","article-title":"Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs","volume":"134","author":"Tan","year":"2009","journal-title":"J Control Release"},{"key":"10.1124\/jpet.118.254466_bib40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2008.04.006","article-title":"Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms","volume":"13","author":"Tang","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.118.254466_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1208\/s12248-012-9433-7","article-title":"Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs","volume":"15","author":"Thomas","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/jpet.118.254466_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2012.02.027","article-title":"In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)","volume":"160","author":"Thomas","year":"2012","journal-title":"J Control Release"},{"key":"10.1124\/jpet.118.254466_bib43","first-page":"45","article-title":"Food deprivation: common sense or nonsense?","volume":"48","author":"Vermeulen","year":"1997","journal-title":"Anim Technol"},{"key":"10.1124\/jpet.118.254466_bib44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/qjmed\/hci139","article-title":"Patient perspectives on multiple medications versus combined pills: a qualitative study","volume":"98","author":"Williams","year":"2005","journal-title":"QJM"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.254466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:53:27Z","timestamp":1739994807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0022356524260468"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.254466","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.254466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}